Individual differences |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |
Barbara A. Cornblatt is currently a Professor of Psychiatry at Albert Einstein College of Medicine and an Investigator at the Feinstein Institute for Medical Research. She conducted research in the Department of Medical Genetics at Columbia University College of Physicians and Surgeons for over 15 years, during which time she focused on identifying risk factors for Schizophrenia. She is the Founder and Co-Director of the International Prodromal Research Network and is currently on the board of directors for the International Early Psychosis Association. She is on the editorial board of the Journal of Early Intervention in Psychiatry and serves as a reviewer for a broad range of psychiatric journals.
Dr. Cornblatt also developed the Continuous Performance Test-Identical Pairs (CPT-IP) version, a measure of attention and working memory that has been used in a large number of studies, both nationally and internationally, and is now considered a standard for measuring neuropsychological change in clinical trials.
She has served on numerous NIMH special interest and review committees.
In 2009, she was awarded the Lorinda de Roulet Award for Excellence in Research from Katz Women’s Hospital and a National Alliance on Mental Illness (NAMI) research award in 2003.
Dr. Cornblatt has been an author on over 100 publications 
- ↑ http://220.127.116.11/nonav.cfm?ID=2651
- ↑ Cornblatt, B., Risch, N., Faris, G., Friedman, D., and Erlenmeyer-Kimling, L.: The Continuous Performance Test, Identical Pairs Version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Research, 26:223-238, 1988.
- ↑ Cornblatt, B., Lenzenweger, M. and Erlenmeyer-Kimling, L.: The Continuous Performance Test-Identical Pairs (CPT-IP): II. Contrasting profiles of attentional deficits in schizophrenic and depressed patients, Psychiatry Research, 29(1):65-85, 1989
- ↑ Cornblatt, B. A., & Kelip, J. G. (1994). Impaired attention genetics, and the patho-physiology of schizophrenia. Schizophrenia Bulletin, 20 (1), 31-46
- ↑ Cornblatt BA, Lencz T, Smith CW, Olsen R, Auther AM, Nakayama E et al. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry 2007; 68(4):546-557